English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Mixed ligand complexes of transition metal ions Co(II), Ni(II), Cu(II) and Zn(II) were synthesized using bidentate Schiff’s base (E)-2-((benzo[d]thiazol-2-yliminomethyl)-6-methoxyphenol (L1), derived from condensation reaction of 2-aminobenzothiazole and 2-hydroxy-3-methoxybenzaldehyde, and 5-Chloro-8-hydroxyquinoline (5CHQ) (L2) as ligands. All the synthesized compounds were characterized using elemental analysis, IR, electronic,  1 H and  13 C NMR spectra, TGA-DTA and Powder XRD analysis, molar conductivity and magnetic susceptibility measurements. Based on the results obtained all the synthesized complexes are proposed to have tetrahedral geometry. All the synthesized compounds were screened for their antioxidant, antimicrobial, antimalarial, antidibetic, anticancer activities and cytotoxicity study using MTT assay. The complexes are proposed to have potential antimalarial, antidibetic and anticancer activities.

Biologically active mixed ligand complexes of Co(II), Ni(II), Cu(II) and Zn(II) as potential antimalarial, antidibetic and anticancer agents